跳至主要内容
临床试验/EUCTR2011-003134-13-NL
EUCTR2011-003134-13-NL进行中(未招募)不适用

5-Aminolevulinic Acid PhotoDynamic Therapy for the treatment of premalignant disorders of the vulva. - ALA-PDT for premalignant vulvar disorders

Erasmus MC0 个研究点开始时间: 2011年11月28日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Erasmus MC

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • - Histologically proven usual type VIN, without invasion or histologically proven LS.
  • - The patient is willing to use a medically acceptable method of contraception throughout the study.
  • - Age 18 and above.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 80

排除标准

  • - (Micro-)invasive carcinoma.
  • - Pregnancy and/or breastfeeding.
  • - Past history of vulvar cancer.
  • - Differentiated (non HPV-related) VIN.
  • - Other treatment of VIN, anogenital warts or LS within 1 month of start treatment.
  • - Hypersensitivity to any components of the cream formulations.
  • - History of psoriasis or other inflammatory dermatosis of the vulva.
  • - Insufficient understanding of the Dutch language.

研究者

发起方
Erasmus MC

相似试验